Trial Details

COMPLETED
Basic Information
Clinical ID c4711
Identifier NCT00078611
Trial Title A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Crohn's Disease
Interventions DRUG: natalizumab
Participant Information
Sponsor Biogen
City Oro Valley
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2004-03
Primary Completion Date 2005-03
Completion Date 2005-03